Jan 21, 2016, 15:12 PM by Michael Croft

SOUTH SAN FRANCISCO, CA - Jan 21, 2016 - Biodesy, Inc., a next-generation protein analysis company, today announced the closing of its $10 million Series B financing and its 20th commercial services agreement using its proprietary, first-in-class technology for measuring protein conformational change

Jan 21, 2016, 11:11 AM by Michael Croft

Phenomena | At the World Economic Forum in Davos, a group of almost 100 pharma companies and trade associations have released a bare bones outline of a plan to spur research into new antibiotics and encourage their responsible use.

Jan 20, 2016, 11:10 AM by Michael Croft

Bio-IT World | An ambitious new study from the Allen Institute for Brain Science illustrates how new methods for isolating and studying single cells, combined with massive RNA sequencing data, are changing the way neuroscientists think about the variety and organization of cells in the brain.

Jan 19, 2016, 10:37 AM by Michael Croft

FARGO, ND - Jan 20, 2016 - CSM, a leading clinical trial supply company, today announced that Brian Swites was promoted to Vice President of Operations and Bob Albanese was named Senior Vice President of Strategic Development

Jan 19, 2016, 09:59 AM by Michael Croft

ST. LOUIS, MO, UNITED STATES - Jan 19, 2016 - The Donald Danforth Plant Science Center announced Elizabeth (Toby) Kellogg , Ph.D., member and principal investigator was selected by the American Association for the Advancement of Science  (AAAS) to serve as chair-elect for the Biological Sciences Section beginning in late February this year

Jan 19, 2016, 05:43 AM by Michael Croft

EDINBURGH, UNITED KINGDOM - Jan 19, 2016 - Aridhia has today announced that it is among 36 organisations behind a ground-breaking Innovative Medicines Initiative research programme that aims to build a platform for efficient testing of innovative treatments for the prevention of Alzheimer’s dementia

Jan 18, 2016, 11:08 AM by Michael Croft

ProPublica | David Epstein tells the story of how a woman whose muscles disappeared discovered, through years of dogged research, that she shared a disease with a muscle-bound Olympic athlete.

Jan 18, 2016, 10:42 AM by Michael Croft

CAMBRIDGE, UNITED KINGDOM - Jan 18, 2016 - Congenica, a world leading developer of genome analysis technologies, places the highest importance on data security and information governance and is therefore pleased to announce that it has successfully achieved two major milestones: ISO 27001 accreditation and compliance with the NHS Information Governance Toolkit (IGT)

Jan 18, 2016, 10:06 AM by Michael Croft

LONDON, UK - Jan 18, 2016 - Titian (www.titian.co.uk) is launching Mosaic SampleBank™ to offer the benefits of sample management best practice, gained from collaborating with big pharma companies, in a format that is cost-effective and rapid for other institutions to deploy

Jan 18, 2016, 06:01 AM by Michael Croft

CAMBRIDGE, UNITED KINGDOM - Jan 18, 2016 - Morphogen-IX, a new Cambridge-based biotech company, has gained seed funding to develop a new treatment for pulmonary arterial hypertension (PAH) that directly targets the major pathway implicated in human genetic studies

Jan 14, 2016, 14:25 PM by Michael Croft

Bio-IT World News Brief | With funding from the National Human Genome Research Institute, and the National Heart, Lung, and Blood Institute, four new Centers for Common Disease Genomics could receive up to $260 million over four years.

Jan 14, 2016, 10:50 AM by Michael Croft

Bio-IT World News Brief | Intellia Therapeutics, one of three major companies developing drugs based on CRISPR-Cas9 gene editing technology, has announced that its ex vivo programs will now be pursued in a new division of the company called eXtellia Therapeutics.

Jan 13, 2016, 12:51 PM by Michael Croft

ST. LOUIS, MO, UNITED STATES - Jan 13, 2016 - The Donald Danforth Plant Science Center announced it has received a three-year grant from the U.S. Department of Agriculture’s (USDA) National Institute of Food and Agriculture (NIFA) to enhance nitrogen use efficiency (NUE)

Jan 12, 2016, 15:05 PM by Michael Croft

ZDNet | Pathway Genomics last week announced that the app the company has been developing with IBM Watson is now in closed alpha release.

Jan 12, 2016, 14:40 PM by Michael Croft

Bio-IT World | The JP Morgan Healthcare Conference comes but once a year. Now it’s here, now it’s here, and Illumina CEO Jay Flatley has honored his seasonal tradition by releasing a new next-generation sequencer in his address to investors.

Jan 12, 2016, 09:44 AM by Michael Croft

PRINCETON, NJ - Jan 12, 2016 - Certara®, the global biosimulation technology-enabled drug development company, today announced the launch of Certara Strategic Consulting China in Shanghai

Jan 11, 2016, 11:10 AM by Michael Croft

Bio-IT World | Illumina, the dominant manufacturer of DNA sequencing technology, has formed a spinoff company called GRAIL to experiment with a pan-cancer blood test, an undertaking for which hundreds of thousands of patients may be enrolled in clinical studies.

Jan 8, 2016, 14:19 PM by Michael Croft

The Atlantic | A new study revises the most famous "fact" about the microbiome: that microbes outnumber human cells in the body ten to one.

Jan 8, 2016, 13:00 PM by Michael Croft

Bio-IT World | In partnership with Illumina, multinational diagnostics company bioMérieux has launched EpiSeq, the first commercial system to monitor outbreaks in hospitals by sequencing and analyzing the whole genomes of bacteria.

Jan 8, 2016, 10:12 AM by Michael Croft

FierceBiotech | Moderna Therapeutics, a high-profile private biotech with scores of preclinical projects, is finally moving toward human trials, recruiting one of the world's largest CROs to help get its much-hyped pipeline moving.